Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse
Author(s) -
Rohan Prasad,
Shaurya Srivastava,
Enhua Wang,
Jason Z. Liu,
Rakesh Gami,
Ayat AbdelGadir,
Akhil Sharma,
S. Rayamajhi,
Richa Tikaria
Publication year - 2021
Publication title -
the permanente journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.445
H-Index - 30
eISSN - 1552-5775
pISSN - 1552-5767
DOI - 10.7812/tpp/21.035
Subject(s) - medicine , rituximab , immunosuppression , covid-19 , immunology , disease , etiology , antibody , intensive care medicine , infectious disease (medical specialty) , virology , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom